In particular, we observed higher anti-leukaemia activity of CAR.CD123-NK cells than NT-NK cells, whereas no significant differences in leukaemia control were found in comparison with T cells genetically modified with the same CAR.CD123. The gene discussed is IL3RA; the disease is leukemia.